Form 4: IonQ Director Sells Shares After Option Exercise

IonQ's Executive Chair, Robert T. Cardillo, reported the exercise of stock options and subsequent sale of common stock, including shares to cover tax liabilities, under a pre-arranged trading plan.

Summary

• Robert T. Cardillo, Director and Executive Chair of IonQ Federal, reported transactions involving IonQ, Inc. common stock.
• On February 26, 2026, Cardillo acquired 2,500 shares of common stock at an exercise price of $11.24 per share through the exercise of stock options.
• Concurrently, on February 26, 2026, Cardillo sold 5,165 shares of common stock at a weighted average price of $39.4356 per share, with prices ranging from $39.00 to $39.90.
• On February 27, 2026, an additional 3,071 shares of common stock were sold at a weighted average price of $39.1924 per share (ranging from $38.1392 to $39.20) to satisfy tax liabilities related to the vesting of restricted stock units.
• All reported transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2025, and amended on June 13, 2025.
• Following these transactions, Cardillo beneficially owns 109,220 shares of common stock and 15,047 derivative securities (stock options).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as slightly negative due to the net reduction in insider holdings, even though the transactions were pre-planned under a Rule 10b5-1 plan and included an option exercise.

Positives

• The exercise of stock options at a price of $11.24 indicates a significant in-the-money position compared to the sale prices of approximately $39.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned, rather than reactive, disposition of shares.

Negatives

• Robert T. Cardillo disposed of a net total of 5,736 shares (8,236 shares sold minus 2,500 shares acquired via option exercise) of IonQ common stock.
• The sale of 5,165 shares represents a direct reduction in the insider's holdings beyond tax obligations.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are common for executives managing their personal portfolios, especially when options vest or restricted stock units are released. For a company in the high-growth quantum computing sector like IonQ, such transactions are often scrutinized for insights into management's confidence, though sales under a 10b5-1 plan are generally considered less indicative of future performance concerns than unplanned sales.

Comparison to Industry Standards

• StockSavvy.ai observes that the use of Rule 10b5-1 trading plans is a standard practice among executives at publicly traded companies across various sectors, including technology and emerging industries like quantum computing. This allows insiders to pre-arrange sales to avoid accusations of trading on material non-public information.
• For example, executives at companies like IBM (which also has quantum computing initiatives) or Google (Alphabet Inc.) frequently utilize similar plans for managing their equity compensation.

Stakeholder Impact

• Shareholders: May interpret the net selling by an executive as a slight negative signal, potentially impacting investor sentiment.

Key Dates

Recommendation

While the net selling by an executive could be perceived negatively, the transactions were executed under a pre-arranged 10b5-1 plan, mitigating concerns of opportunistic selling. The executive still retains a substantial holding of common stock and options. Investors should monitor future insider activity and company performance rather than reacting solely to this planned disposition.

Keywords

IonQ, IONQ, Robert T. Cardillo, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Quantum Computing, Executive Chair